The Turkish journal of pediatrics, vol.62, pp.379-386, 2020 (Journal Indexed in SCI)
Article / Article
Title of Journal :
The Turkish journal of pediatrics
IVIG, adverse reaction, primary immunodeficiencies, COMMON VARIABLE IMMUNODEFICIENCY, REPLACEMENT THERAPY, HUMORAL IMMUNODEFICIENCY, FOLLOW-UP, EFFICACY, CHILDREN, IVIG, CLASSIFICATION, PREVENTION, 5-PERCENT
Background and objective. Adverse reactions related to intravenous immunoglobulin (IVIG) infusions vary from 1 to 81%, with an average of 20%. They may be classified as immediate; occurring during the infusion itself or delayed; occurring after the infusion has been ceased. In the present study, we aimed to evaluate the frequency of immediate adverse reactions due to IVIG infusions in primary immune deficiency (PID) patients.